LEIDEN, NETHERLANDS--(Marketwire - March 12, 2008) - London, March 12, 2008 - Dutch biopharma company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: SW CRX) today presents an update on the company’s performance, strategy for growth acceleration and a review of the company’s pipeline at a meeting for investors and analysts in London. A live audio webcast of the meeting, together with the program and slides of all presentations, will be available on Crucell’s website at www.crucell.com.
